Q1: Lower cost, higher run-off gains and better financials. Adj. EPS up by 3.7%, 2.8% and 2.6%, for '24-26e. Valuation premium and low yield make it unattractive.
Cold start, storms and snow set the stage for higher frequency claims. Underl. claims improved from last year's repricing and changed terms. Negative risk/reward in both Tryg and Top from UW & financials.
Q1e: another poor weather quarter combined with Oona headwind. Adj. EPS trimmed by 5% for '24e (claims) but unchanged for '25e. Valuation premium down a bit more (now 10-12%); stay away.
Q4 had even tougher weather, but underlying UW just better. Adj. EPS in '24e down 4% and '25e down 6% amid costs. Valuation premium and low yield makes it unattractive.
Larger changes to interest rate and colder weather are main topics. Underl. CR improved, but interest rates affect both CR & financials. Prefer Tryg & Sampo (both BUY) over GJF (HOLD) & Top (SELL).
Q4e: weather and dis-synergies to hit CR, underl. CR could improve. Adj. EPS trimmed for 23e-24e, up 4% for '25e (premiums). Overly high valuation premium to peers given its total yield: SELL.
Q3: mixed frequency; fire (pos) motor (neg), but there seems to be other effects (repricing above inflation) that lifts estimates 1%. Valuation premium still too solid, even dividend-adjusted – SELL.
Rain, storms and flooding leave their mark on the quarter. CR for '23e down (weather), stable '24e-'25e levels (pricing discipline). Prefer Tryg, Solid & Sampo (all BUY) over GJF (HOLD), Top (SELL).
Q3e: weather events to hit reported, frequency to hit underlying CR. Adj. EPS down 10% in '23e, -2% in both '24e-'25e (lower premiums). Fairly valued and overly low yield leaves it unattractive: SELL
Miss consensus net profit by 28% from financials & frequency. New guidance include higher motor frequency in 2H. Cons. est. rev -6-12% for 23e; Stock could continue -5%
Two large losses announced, several not, hurting Q2e CR. Combined ratio (CR) up in '24e-'25e on pricing discipline. Prefer Tryg (BUY) over Sampo & GJF (both HOLD), Top (SELL).
Q2e: cost ratio up (dis-synergies) and claims (freq. & re-ins.). Adj. EPS in '24e-'25e up on better CR. Increasingly fairly valued, but still our relative funding (SELL).
We continue to favour Tryg and STB, followed by Sampo. Inflation & repricing still key - separates winners from losers. P&C insurance remains robust during weaker macro.
Net profit DKK 373m, +14% vs. cons. driven by financials. CR guidance at 82.5-85.5% (ex.run-off); cons at 83.6%. Cons.est.rev. likely +1-3% on ‘23e, less for 24e-25e.